Comparison of Hormonal Therapy and Chemohormonal Therapy in Patients with Newly Diagnosed Clinical Stage D Prostatic Cancer
Open Access
- 1 November 1996
- journal article
- clinical trial
- Published by Wiley in International Journal of Urology
- Vol. 3 (6) , 472-477
- https://doi.org/10.1111/j.1442-2042.1996.tb00579.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- CLINICOPATHOLOGICAL EVALUATION OF ETOPOSIDE OR ESTRAMUSTINE PHOSPHATE IN CASTRATED PATIENTS WITH ADVANCED PROSTATIC CANCERThe Japanese Journal of Urology, 1995
- Perspectives on Cancer in Japan and the United States'Japanese Journal of Cancer Research, 1993
- A Multicenter Randomized Trial Comparing the Luteinizing Hormone-Releasing Hormone Analogue Goserelin Acetate Alone and with Flutamide in the Treatment of Advanced Prostate CancerJournal of Urology, 1991
- Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic CarcinomaBritish Journal of Urology, 1991
- Advanced Prostatic CarcinomaUrologic Clinics of North America, 1991
- TREATMENT FOR NEWLY DIAGNOSED STAGE D2 PROSTATIC CARCINOMA WITH HORMONAL THERAPY ALONE, OR CHEMOTHERAPY AGENTS IN COMBINATION WITH HORMONESThe Japanese Journal of Urology, 1991
- Prostate cancer. ChemotherapyCancer, 1987
- Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancerUrology, 1986
- Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)Cancer, 1980